Two UT Health San Antonio researchers lead an American Heart Association scientific statement aimed at early recognition and intervention for post-stroke spasticity, painful muscle stiffness and ...

The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...

Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...